Global Uterine Fibroid Treatment Devices Market is segmented based on Type, Technology, End-Users, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Uterine Fibroid Treatment Devices Market is segmented based on Type, Technology, End-Users, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
Introduction

The Global Uterine Fibroid Treatment Device Market is estimated to be USD 5.55 Bn in 2023 and is expected to reach USD 6.86 Bn by 2028, growing at a CAGR of 4.32%.

The Uterine Fibroid Treatment Devices Market refers to the market for medical devices used in the treatment of uterine fibroids. Uterine fibroids are non-cancerous tumors that grow in or on the uterus and affect many women worldwide.

The market is mainly driven by the prevalence of uterine fibroids among women worldwide. According to the National Institutes of Health (NIH), uterine fibroids affect 20-80% of women by age 50. Studies have also shown that African American women are two to three times more likely to develop fibroids than women of other racial or ethnic groups. The exact cause of uterine fibroids is unknown, but they are thought to be related to hormonal imbalances, genetics, and environmental factors. Several factors may contribute to the rising prevalence of uterine fibroids, including a sedentary lifestyle and unhealthy dietary habits, delayed childbearing, and obesity. Additionally, certain medications, such as hormone replacement therapy, may increase the risk of developing uterine fibroids.

However, the high cost of uterine fibroid devices may affect the accessibility of these devices to patients, hindering segment growth.

Furthermore, the market has an opportunity due to advancements in diagnosing and treating uterine fibroids. The development of new technologies and treatment options has helped to improve the accuracy of diagnosis and to offer more effective and less invasive treatment options for patients. For example, introducing robotic-assisted surgery for uterine fibroids has made the procedure less invasive and more precise.

Additionally, the market is challenged by complications associated with fibroid. Some complications include the risk of infection, bleeding, Pain, etc. In some cases, uterine fibroid treatment devices can lead to the formation of adhesions, or scar tissue, in the uterus. This can potentially lead to infertility or other complications. In addition, the devices, such as morcellators, have been associated with specific device-related complications such as tissue damage, the spread of cancerous cells, and other adverse events.

Market Segmentations

The Global Uterine Fibroid Treatment Devices Market is segmented based on Type, Technology, End-Users, and Geography.

By Type, the market is classified into Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, and Pedunculated Fibroids. Subserosal fibroids are contributing to the growth of the uterine Fibroid Treatment Devices market. It has significant symptoms such as pelvic pain and pressure and can grow quite large, which may require surgical intervention. The increasing prevalence of uterine fibroids, particularly subserosal fibroids, and the availability of new treatment options have contributed to the growth of the uterine Fibroid Treatment Devices market in recent years. The market includes a range of devices, such as laparoscopic instruments, hysteroscopes, ultrasound devices, and ablation devices, among others.

By Technology, the market is classified into Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, and Embolization Techniques. Laparoscopic techniques are growing in popularity as a treatment option for uterine fibroids. It has led to growth in the uterine Fibroid Treatment Devices market. It involves making small incisions in the abdomen and using specialized instruments to remove or destroy the fibroids. It is a minimally invasive surgical procedure that involves removing the fibroids while leaving the uterus intact. This procedure has become increasingly popular in recent years as an alternative to hysterectomy, which involves removing the entire uterus and is a more invasive surgical procedure.

By End-Users, the market is classified into Hospitals & Clinics and Ambulatory Surgical Centers. The hospitals & Clinics segment is the largest growing segment because the diagnosis and treatment of uterine fibroids typically require specialized medical equipment and expertise only available in hospital and clinic settings. Hospitals and clinics are often the first point of contact for patients seeking diagnosis and treatment for their symptoms.

By Geography, the market is classified into the Americas, Europe, Middle-East & Africa, and Asia-Pacific. Asia Pacific is one of the growing regions for the uterine fibroid treatment devices market. The region is experiencing rapid economic growth. In addition, there is increasing demand for advanced medical technologies and treatments. The large population in countries like China and India also contributes to the market's growth. There is a high prevalence of uterine fibroids in these regions. Further, it has led to the development of advanced treatment options and increased availability of uterine fibroid treatment devices in the Asia Pacific market.

Recent Development

Myovant Sciences and Pfizer Inc. announced that the United States Food and Drug Administration (FDA) had approved MYFEMBREE, the first once-daily treatment for managing heavy menstrual bleeding associated with uterine fibroids in premenopausal women, with a treatment duration of up to 24 months. - May 2021

Pfizer and Myovant released favorable results from the Phase III LIBERTY 1 and LIBERTY 2 investigations. In women with uterine fibroids, the companies are testing a once-daily combination therapy of relugolix plus estradiol and norethindrone acetate. - February 2021

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Hologic, Insightec, Intuitive Surgical, Karl Storz, Lumenis, etc.

Countries Studied

America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxemburg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

Middle-East and Africa (Egypt, Israel, Nigeria, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

IGR Competitive Quadrant

The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Uterine Fibroid Treatment Devices Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

Infogence Global Research analyses the Global Uterine Fibroid Treatment Devices Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, Infogence Global Research has devised suitable strategies for market growth.

Why buy this report?The report offers a comprehensive evaluation of the Global Uterine Fibroid Treatment Devices Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.Excel data sheet for the market size will also be provided with the report.The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitorsThe report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.Report Highlights:A complete analysis of the market, including the parent industryImportant market dynamics and trendsImpact Analysis – a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.Market segmentationCompetitive Analysis: Comparative analysis of competitorHistorical, current, and projected size of the market based on value and volumeMarket size of the US statesMarket shares and strategies of key playersRecommendations to companies for strengthening their foothold in the market